Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS ISSUE:
May 2013

Iloperidone Increases QTc
Coadministration of drugs that inhibit cytochrome P450 2D6 or 3A4 increases the potential for iloperidone (Fanapt) to prolong the QTc interval.

Diabetes and Dyslipidemia: Risks for Adolescents with Mental Illness
A retrospective cohort study found that adolescents with schizophrenia or bipolar disorder had higher rates of both diabetes and dyslipidemia.

Memantine for FTD: A Negative Study
In a double-blind, parallel-group study, memantine (Namenda) produced no benefit greater than placebo for patients with frontotemporal dementia but more frequent cognitive adverse events.

Inappropriate Sexual Behavior in FTD: A Case Report
Aripiprazole (Abilify) reduced inappropriate sexual behavior in an elderly man with frontotemporal dementia.

In Brief
Age and Dose Play a Role in the Effects of Antidepressants on Fracture Risk; Weight Management Intervention Program Beneficial for Patients with Schizophrenia

Hypertension following SSRI Withdrawal
A woman with depression experienced hypertension when citalopram (Celexa and others) was abruptly discontinued.

Iloperidone Increases QTc

May 2013

The first-generation antipsychotic thioridazine (Mellaril and others) has largely disappeared from use because it substantially prolongs the cardiac QTc interval. A lengthened QTc can predispose patients to torsade de pointes, a potentially lethal ventricular arrhythmia. The second-generation antipsychotic…

To view the rest of this article, please: